Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.
Ide H, Lu Y, Yu J, China T, Kumamoto T, Koseki T, Yamaguchi R, Muto S, Horie S.
Prostate. 2012 Jan 30. doi: 10.1002/pros.22492. [Epub ahead of print]
Related citations
HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis.
Zhang ZY, Schluesener HJ.
Prostate. 2012 Jan;72(1):90-9. doi: 10.1002/pros.21410. Epub 2011 May 2.
TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug.
Slabáková E, Pernicová Z, Slavíčková E, Staršíchová A, Kozubík A, Souček K.
Prostate. 2011 Sep;71(12):1332-43. doi: 10.1002/pros.21350. Epub 2011 Feb 14.
Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy.
Niu Y, Ge R, Hu L, Diaz C, Wang Z, Wu CL, Olumi AF.
Prostate. 2011 Sep;71(12):1317-24. doi: 10.1002/pros.21348. Epub 2011 Feb 9.
Parathyroid hormone is not involved in prostate growth in patients with benign prostatic hyperplasia.
Kim WT, Choi YD, Park C, Kim YW, Yun SJ, Kim IY, Kim WJ.
Prostate. 2011 Aug 1;71(11):1210-5. doi: 10.1002/pros.21336. Epub 2011 Jan 12.
An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate.
Haverkamp JM, Charbonneau B, Crist SA, Meyerholz DK, Cohen MB, Snyder PW, Svensson RU, Henry MD, Wang HH, Ratliff TL.
Prostate. 2011 Aug 1;71(11):1139-50. doi: 10.1002/pros.21327. Epub 2011 Jan 12.
Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.
Thomas LN, Morehouse TJ, Too CK.
Prostate. 2012 Mar;72(4):450-60. doi: 10.1002/pros.21446. Epub 2011 Jun 17.
Anti-angiogenic effects and mechanism of prazosin.
Liao CH, Guh JH, Chueh SC, Yu HJ.
Prostate. 2011 Jun 15;71(9):976-84. doi: 10.1002/pros.21313. Epub 2010 Dec 6.
Internal prostatic architecture on transrectal ultrasonography predicts future prostatic growth: natural history of prostatic hyperplasia in a 15-year longitudinal community-based study.
Fukuta F, Masumori N, Mori M, Tsukamoto T.
Prostate. 2011 May;71(6):597-603. doi: 10.1002/pros.21275. Epub 2010 Oct 13.
Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer.
Chiriva-Internati M, Yu Y, Mirandola L, D'Cunha N, Hardwicke F, Cannon MJ, Cobos E, Kast WM.
Prostate. 2012 Jan;72(1):12-23. doi: 10.1002/pros.21400. Epub 2011 Apr 25.
Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia.
Robert G, Smit F, Hessels D, Jannink S, Karthaus HF, Aalders T, Jansen K, de la Taille A, Mulders PF, Schalken JA.
Prostate. 2011 Nov;71(15):1701-9. doi: 10.1002/pros.21387. Epub 2011 Mar 28.
VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
Mori F, Tanigawa K, Endo K, Minamiguchi K, Abe M, Yamada S, Miyoshi K.
Prostate. 2011 Mar 10. doi: 10.1002/pros.21374. [Epub ahead of print]
Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
Sugimoto M, Oka M, Tsunemori H, Yamashita M, Kakehi Y.
Prostate. 2011 Mar 1;71(4):438-44. doi: 10.1002/pros.21299. Epub 2010 Oct 28.
Prostate. 2011 Jan 12. [Epub ahead of print]
Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Wang X, Hickey RJ, Malkas LH, Koch MO, Li L, Zhang S, Sandusky GE, Grignon DJ, Eble JN, Cheng L.
Prostate. 2011 May 15;71(7):748-54. doi: 10.1002/pros.21291. Epub 2010 Oct 28.
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
Rick FG, Schally AV, Block NL, Halmos G, Perez R, Fernandez JB, Vidaurre I, Szalontay L.
Prostate. 2011 May 15;71(7):736-47. doi: 10.1002/pros.21289. Epub 2010 Oct 13.
The effect of estrogen supplementation on cell proliferation and expression of c-kit positive cells in the rat prostate.
Kusljic S, Exintaris B.
Prostate. 2010 Oct 1;70(14):1555-62.
Muscarinic receptors and their mRNAs in type 2 Goto-Kakizaki diabetic rat prostate.
Saito M, Kazuyama E, Shimizu S, Dimitriadis F, Kinoshita Y, Masuda E, Yamada S, Satoh K.
Prostate. 2010 Oct 1;70(14):1533-9.
Receptors for luteinizing hormone-releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix.
Rozsa B, Nadji M, Schally AV, Dezso B, Flasko T, Toth G, Mile M, Block NL, Halmos G.
Prostate. 2011 Apr;71(5):445-52. doi: 10.1002/pros.21258. Epub 2010 Sep 21.
A transcriptional signature associated with the onset of benign prostate hyperplasia in a canine model.
Gallardo-Arrieta F, Doll A, Rigau M, Mogas T, Juanpere N, García F, Morote J, Nuñez F, Abal M, Lloreta J, Reventós J.
Prostate. 2010 Sep 15;70(13):1402-12.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on